Statements (11)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:alternativeName |
GSK-8341
|
gptkbp:canBe |
treatment of type 2 diabetes
|
gptkbp:CASNumber |
1441674-54-6
|
gptkbp:developedBy |
GlaxoSmithKline
|
gptkbp:drugClass |
GLP-1 receptor agonist
|
gptkbp:hasMolecularFormula |
C20H19ClN4O2S
|
https://www.w3.org/2000/01/rdf-schema#label |
GDM-8341
|
gptkbp:status |
investigational drug
|
gptkbp:bfsParent |
gptkb:GDM_series
|
gptkbp:bfsLayer |
8
|